Are all criteria of metabolic syndrome equally harmful?

Acta Cardiologica

Volumn 66, Issue 2, 2011, Pages 189-196

  Ivanovic, Branislava A ^a   Tadic, Marijana V ^a   Simic, Dragan V ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Diastolic function; Global function; Left ventricular structure; Metabolic syndrome

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE SIZE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PULSE WAVE; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; TISSUE DOPPLER IMAGING; TWO DIMENSIONAL ECHOCARDIOGRAPHY; WAIST CIRCUMFERENCE;

BLOOD GLUCOSE; BLOOD PRESSURE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART DISEASES; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT; WAIST CIRCUMFERENCE;

EID: 79955782789     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.66.2.2071250     Document Type: Article

References (37)

1. Doshi KB, Kashyap SR, Brennan DM, Hoar BM, Cho L, Hoogwerf BJ. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study. Diabetes Obes Metab 2009; 11: 102-8.
2. Stern MP, Williams K, Gonzalez-Villalpando C, Hunt KJ, Haffner SM. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 2004; 27: 2676-81.
3. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-9.
4. Cuspidi C, Meani S, Fusi V, Severgnini B, Valerio C, Catini E, Leonetti G, Magrini F, Zanchetti A. Metabolic syndrome and target organ damage in untreated essential hypertensives. J Hypertens 2004; 22: 1991-8.
5. Ferrara LA, Cardoni O, Mancini M, Zanchetti A. Metabolic syndrome and left ventricular hypertrophy in a general population. Results from the Gubbio Study. J Hum Hypertens 2007; 21: 795-801.
6. de las Fuentes L, Brown A, Mathews S, Waggoner A, Soto P, Gropler R, Davila-Roman G. Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass. Eur Heart J 2007; 28: 553-9.
7. Masugata H, Senda S, Goda F, Yoshihara Y, Yoshikawa K, Fujita N, Daikuhara H, Nakamura H, Taoka T, Kohno M. Left ventricular diastolic dysfunction as assessed by echocardiography in metabolic syndrome. Hypertens Res 2006; 29: 897-903.
8. Mahmud A, Almuntaser I, Brown A, King G, Crean P, Feely J. Left ventricular structural and functional changes in the metabolic syndrome. J Cardiometab Syndr 2009; 4: 81-8.
9. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
10. WHO Guideline Development Committee. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. Report of a WHO/IDF Consultation, Geneva 2006.
11. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A; ESH-ESC Task Force on the Management of Arterial Hypertension. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 2007; 25: 1751-62.
12. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-67.
13. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613-8.
14. Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA. Recommendations for quantification of Doppler echocardiography: A report from the Doppler Quantification Task Force of The Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002; 15: 167-84.
15. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelisa A. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 2009; 10: 165-93.
16. Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ, Tajik AJ, Seward JB. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function - a study in normals and dilated cardiomyopathy. J Cardiol 1995; 26: 357-66.
17. WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Geneva, Switzerland: World Health Organization; 1999: 31-3.
18. Alberti KG, Zimmet P, Shaw J; the IDF Epidemiology Task Force Consensus Group. The metabolic syndrome: a new worldwide definition. Lancet 2005; 366: 1059-62.
19. Grundy SM, Brewer HB Jr., Cleeman JI, Smith SC Jr., Lenfant C; American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433-8.
20. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K; DECODE Study Group. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 2004; 164: 1066-76.
21. Mancia G, Bombelli M, Facchetti R, Casati A, Ronchi I, Quarti-Trevano F, Arenare F, Grassi G, Sega R. Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events. J Hypertens 2010; 28: 999-1006.
22. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, Rinfret S, Schiffrin EL, Eisenberg MJ. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010; 56: 1113-32.
23. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, Montori VM. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007; 49: 403-14.
24. Koutsovasilis A, Protopsaltis J, Triposkiadis F, Kokkoris S, Milionis HJ, Zairis MN, Skoularigis J, Koukoulis G, Korantzopoulos P, Melidonis A, Foussas SG. Comparative performance of three metabolic syndrome definitions in the prediction of acute coronary syndrome. Intern Med 2009; 48: 179-87.
25. Yoon YS, Lee ES, Park C, Lee S, Oh SW. The new definition of metabolic syndrome by the international diabetes federation is less likely to identify metabolically abnormal but non-obese individuals than the definition by the revised national cholesterol education program: the Korea NHANES study. Int J Obes (Lond) 2007; 31: 528-34.
26. Berk BC, Fujiwara K, Lehoux S. ECM remodeling in hypertensive heart disease. J Clin Invest 2007; 117(3): 568-575.
27. Sundström J, Ärnlöv J, Stolare K, Lind L. Blood pressure-independent relations of left ventricular geometry to the matabolic syndrome and insulin resistance: a population-based study. Heart 2008; 94: 874-8.
28. Powell B, Redfield M, Bybee K, Freeman W, Rihal C. Association of obesity with left ventricular remodeling and diastolic dysfunction in patients without coronary artery disease. Am J Cardiol 2006; 98: 116-20.
29. Mancia G, Bombelli M, Corrao G, Facchetti R, Madotto F, Giannattasio, Trevano FQ, Grassi G, Zanchetti A, Sega R. Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni PAMELA study: daily life blood pressure, cardiac damage, and prognosis. Hypertension 2007; 49: 40-7.
30. Chinali M, Devereux RB, Howard BV, Roman MJ, Bella JN, Liu JE, Resnick HE, Lee ET, Best LG, de Simone G. Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study). Am J Cardiol 2004; 93: 40-4.
31. Ferrara L, Guida L, Ferrara F, De Luca G, Staiano L, Celentano A, Mancini M. Cardiac structure and function and arterial circulation in hypertensive patients with and without metabolic syndrome. J Hum Hypertens 2007; 21: 729-35.
32. Aijaz B, Ammar K, Lopez-Jimenez F, Redfield M, Jacobsen S, Rodeheffer R. Abnormal cardiac structure and function in the metabolic syndrome: a population-based study. Mayo Clin Proc 2008; 83: 1350-7.
33. Fuentes L, Waggoner AD, Brown Al, Dávila-Román VG. Plasma triglyceride level is an independent predictor of altered left ventricular relaxation. J Am Soc Echocardiogr 2005; 18: 1285-91.
34. Turhan H, Yasar AS, Yagmur J, Kurtoglu E, Yetkin E. The impact of metabolic syndrome on left ventricular function: evaluated by using the index of myocardial performance. Int J Cardiol 2009; 132: 382-6.
35. Mishra RK, Kizer JR, Palmieri V, Roman MJ, Galloway JM, Fabsitz RR, Lee ET, Best LG, Devereux RB. Utility of the myocardial performance index in a population with high prevalences of obesity, diabetes, and hypertension: The Strong Heart Study. Echocardiography 2007; 24: 340-7.
36. Voulgari C, Moyssakis I, Papazafiropoulou A, Perrea D, Kyriaki D, Katsilambros N, Tentolouris N. The impact of metabolic syndrome on left ventricular myocardial performance. Diabetes Metab Res Rev 2010; 26: 121-7.
37. Su HM, Lin TH, Voon WC, Lee KT, Chu CS, Yen HW, Lai WT, Sheu SH. Correlation of Tei index obtained from tissue Doppler echocardiography with invasive measurements of left ventricular performance. Echocardiography 2007; 24: 252-7.